Home/Filings/4/0001156039-23-000025
4//SEC Filing

Gallina John E 4

Accession 0001156039-23-000025

CIK 0001156039other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 4:15 PM ET

Size

11.7 KB

Accession

0001156039-23-000025

Insider Transaction Report

Form 4
Period: 2023-03-01
Gallina John E
SVP & Chief Accounting Officer
Transactions
  • Tax Payment

    Common Stock

    2023-03-02$468.78/sh4,650$2,179,82763,725 total
  • Tax Payment

    Common Stock

    2023-03-01$469.03/sh587$275,32155,594 total
  • Award

    Common Stock

    2023-03-01+3,06558,659 total
  • Award

    Common Stock

    2023-03-01+9,71668,375 total
  • Award

    Employee Stock Option (Right to Buy)

    2023-03-01+11,78211,782 total
    Exercise: $469.03Exp: 2033-03-01Common Stock (11,782 underlying)
Footnotes (4)
  • [F1]PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
  • [F2]Represents restricted share units. Restrictions lapse as follows: 1,021 shares on 3/1/2024, and 1,022 shares each on 3/1/2025 and 3/1/2026.
  • [F3]Represents performance based restricted share units. Restrictions lapse on 3/2/2023.
  • [F4]The option represents a right to purchase a total of 11,782 shares, and is exercisable in two installments of 3,927 shares each and one installment of 3,928 shares, beginning on 3/1/2024, which is the one-year anniversary of the option grant date.

Issuer

Elevance Health, Inc.

CIK 0001156039

Entity typeother

Related Parties

1
  • filerCIK 0001433032

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:15 PM ET
Size
11.7 KB